Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis.

Saved in:
Bibliographic Details
Title: Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis.
Authors: Tiraboschi, Gilles1 (AUTHOR) gilles.tiraboschi@sanofi.com, Papp, Kim2,3 (AUTHOR), Bieber, Thomas4 (AUTHOR), Weidinger, Stephan5 (AUTHOR), Beck, Lisa6 (AUTHOR), Lee, Chih‐Hung7 (AUTHOR), O'Malley, John T.8 (AUTHOR), Yen, Karl9 (AUTHOR), Bernigaud, Charlotte10 (AUTHOR), Fabre, David1 (AUTHOR), Hurbin, Fabrice1 (AUTHOR)
Source: CPT: Pharmacometrics & Systems Pharmacology. Dec2025, Vol. 14 Issue 12, p2161-2172. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21638306
DOI:10.1002/psp4.70121